Which of the following is a combination of Glycopyrrolate and Indacaterol?

The correct combination of Glycopyrrolate and Indacaterol is found in Utibron Neohaler. This medication is designed specifically to assist in managing chronic obstructive pulmonary disease (COPD) by utilizing both components: Glycopyrrolate, which is an anticholinergic bronchodilator that helps to relax the muscles in the airways, and Indacaterol, which is a long-acting beta agonist that widens the airways to improve breathing.

The synergy of these two medications enhances bronchodilation and provides relief from symptoms associated with COPD. The formulation of Utibron Neohaler is aimed at providing sustained efficacy over time, making it particularly suitable for chronic respiratory conditions.

While the other options may involve different combinations of medications used for respiratory conditions, they do not contain both Glycopyrrolate and Indacaterol. Option A, Bevespi Aerosphere, combines Glycopyrrolate with another medication but not Indacaterol. Option B, Anoro Ellipta, contains Umeclidinium and Vilanterol instead, and Option C, Stioloto, comprises Olodaterol and Tiotropium. Understanding these specific combinations is crucial for managing patient